- Exchange: Xetra
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharma
MagForce AG+ Add to Watchlist
MF6:GR5.500 EUR 0.255 4.86%
As of 11:36:00 ET on 12/19/2014.
Company Profile for MagForce AG (MF6)
Magforce AG develops medical technologies. The Company specializes in nanocancer therapy for treatment of cancerous tumors. Magforce's treatment uses nanoparticles containing ironoxide, which are injected into solid tumors in a procedure similar to a biopsy.
Key Executives for MagForce AG (MF6)
|Benjamin J Lipps "Ben"Chairman-Mgmt Board/CEO||Christian Von VolkmannCFO/Member-Mgmt Board|
|Hoda TawfikCOO/CMO:Therapy Dev|